Elderly Blindness Drug Impresses FDA Panel
683350
A drug that attacks a major form of elderly blindness passed a key hurdle Friday as the government&#39;s scientific advisers decided that it poses no significant risks.
390562
WASHINGTON - There's a new option for people who suffer from extreme nearsightedness, whose world loses its crisp edge just a few inches from their noses. The first implantable lens for nearsightedness was approved Monday by the Food and Drug Administration...
534094
Two new studies give one more reason to eat a diet rich in fish: prevention of age-related macular degeneration, the leading cause of blindness in old age.
289520
WEDNESDAY, Sept. 12 (HealthDay News) -- People who consume high levels of the yellow plant pigments lutein and zeaxanthin may have a reduced risk of developing age-related macular degeneration (AMD), a leading cause of irreversible blindness among the elderly.
705948
ROCKVILLE, Md.  - An experimental drug developed  by Eyetech Pharmaceuticals Inc. and Pfizer Inc. for preserving  vision in the elderly received a generally positive review from  a U.S. advisory panel on Friday.
190069
The FDA issues a health advisory for a top Pfizer drug.
420195
Medarex's lead drug gets an important yet expected designation from the FDA.
700256
A derivative of an ingredient in red wine can combat symptoms of aging according to a new study from Sirtris Pharmaceuticals.
519863
The company faces a pivotal clinical trial.
45674
A scientific report released today suggests that older men with high lead concentrations in their bodies have a much higher risk of developing cataracts, the leading cause of blindness.
168198
A drug to treat a common eye disease that damages vision produced promising results in a major trial, researchers say.
529837
Neurochem hints at the data for its Alzheimer's disease drug candidate.
18405
The Food and Drug Administration on Tuesday approved a drug for multiple sclerosis that has shown early evidence of being more effective than existing drugs.
751523
A new addition to an already successful drug promises good results for investors.
260486
A team of Finnish researchers has developed a drug that could be a major advancement in treating degenerative diseases, including Alzheimer's. The team, working with Tampa's Johnnie B. Byrd Sr.
321830
The FDA grants a speedy review for Millennium's lead drug.
487273
Although the experiment suggests a possible treatment for age-related macular degeneration, many uncertainties remain to be addressed.